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Abstract 
The present work consists of the data of multicentric clinical study conducted on Iron 
Deficiency Anaemia (Pandu Roga) with an Ayurvedic formulation, Dhatri Lauha. The 
objective of current study was to assess the clinical safety and efficacy of Dhatri Lauha in the 
patients of Iron Deficiency Anaemia through measurable objective parameters. This 
multicentric study was conducted in 12 peripheral research institutes of Central Council for 
Research in Ayurvedic Sciences, Department of AYUSH, Ministry of Health & Family 
Welfare, Government of India, New Delhi to evaluate the safety and efficacy of Dhatri Lauha 
with 45 days of treatment. Total 458 Patients were enrolled in this study out of which 400 
patients had successfully completed it. 
Cluster Sampling techniques were used for the analysis of the data on the objective 
parameters such as weakness, fatigue, palpitation, breathlessness and swollen feet. There has 
been little work done on methods for cluster analysis of the data where the outcome measure 
is an event rate (per person time).  
This work contributes to the application of the statistical techniques for analysis of the 
Bio-medical studies data. 
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Introduction 
Iron deficiency anaemia (IDA) is the 
most common nutritional deficiency 
worldwide. Iron deficiency can arise either 
due to inadequate intake or poor 
bioavailability of dietary iron or due to 
excessive loss of iron from the body.  The 
poor bioavailability of dietary iron is 
considered to be major reason for widespread 
iron deficiency (7).  Women lose a 
considerable amount of iron in menstruation. 
Some other factors leading to anaemia are 
intestinal parasites (hookworm etc.) and 
malaria. 
According to Ayurveda, Pandu is 
considered as a specific disease characterized 
by pallor of body which strikingly resembles 
with „Anaemia‟ of modern science. Detailed 
description concerning the etiology, 
pathogenesis, classification and management 
of anaemia (Pandu roga) is available in 
classical literatures of Ayurveda. Correcting 
anaemia often requires an integrated approach 
due to multifactorial nature of this disease, in 
order to effectively combat it, the contributing 
factors must be identified and addressed. In 
settings where iron deficiency is the most 
frequent cause, additional iron intake is 
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usually provided through iron supplements. 
There are many age-old remedies for the 
treatment of this condition in Ayurveda. 
 
Cluster Sampling 
Cluster sampling is a sampling 
technique in which the entire population of 
interest is divided into groups, or clusters, 
and a random sample of these clusters is 
selected. Each cluster must be mutually 
exclusive and together the clusters must 
include the entire population. 
 After clusters are selected, then all 
units within the clusters are selected. No 
units from non-selected clusters are 
included in the sample. This differs from 
stratified sampling, in which some units 
are selected from each group. When all the 
units within a cluster are selected, the 
technique is referred to as one-stage cluster 
sampling.  
If a subset of units is selected 
randomly from each selected cluster, it is 
called two-stage cluster sampling. Cluster 
sampling can also be made in three or 
more stages: it is then referred to as 
multistage cluster sampling.  
 
Cluster Randomized Trials 
Clinical trials typically involve the 
randomization of individual subjects to the 
intervention or control groups (4). Cluster 
randomized trials are however, characterized 
by the randomization of groups or clusters of 
individuals (such as schools, medical 
practices, communities, research units) to 
treatment groups (6). Such designs are used 
increasingly frequently in trials of preventive 
interventions, for example of the effects of 
Vitamin A supplementation, Haemoglobin 
supplementation, etc. 
Several methods have been developed 
for the statistical analysis of cluster 
randomized trials. These includes simple 
techniques such as the t-test, the Wilcoxon 
rank sum test and Fisher‟s permutation test, 
which use the proportion of individuals 
experiencing the event in each cluster as the 
observation. 
There has been a little work done on 
methods for the analysis of cluster 
randomized trials where the outcome measure 
is an event rate (per person time) such as 
mortality, or incidence rate of a disease or a 
symptom of particular disease, rather than a 
proportion. The present study aims to fulfil 
that gap.  
In the present study researcher wishes 
to test the efficacy of an Ayurvedic 
Formulation Dhatrilauha in the patients of 
Iron Deficiency Anemia by making use of 
cluster sampling techniques. 
 
Study Design (8) 
The present work consists of the 
data of multicentric clinical study 
conducted on Iron Deficiency Anaemia 
(Pandu Roga) with an Ayurvedic 
formulation Dhatri Lauha in the dose of 
500 mg. (one capsule) twice daily after 
meal for forty five (45) days with 
lukewarm water. Dhatri Lauha comprises 
of pericarp of Amalaki, Lauha Bhasma, 
root of Yastimadhu and stem of Guduchi. 
The objective of current study was 
to assess the clinical safety and efficacy of 
Dhatri Lauha through measurable 
objective parameters over a period of 45 
days divided into four assessment stages 
after a gap of 15 days each. Hence there 
were four assessment stages viz; Stage I - 
0 day (Recruitment day of the patient), 
Stage II – After 15 days, Stage III – After 
30 days and Stage IV – After 45 days. 
This multicentric study was 
conducted in 12 peripheral research 
institutes of Central Council for Research 
in Ayurveda and Siddha, Department of 
AYUSH, Ministry of Health & Family 
Welfare, Government of India. Central 
Council for Research in Ayurveda & 
Siddha has 35 units all across the country.  
Before the initiation of the study it 
was planned to design the study as cluster 
randomized trial. Hence out of 35 
institutes 12 institutes were selected 
randomly. These selected institutes formed 
our 12 clusters for the present study.  
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A target of 40 patients was fixed 
for each of the 12 centres. Hence a total of 
480 patients was the Sample size for this 
study. Out of these 480 patients it was 
possible to achieve the target of total 458 
Patients which were enrolled in this study. 
Out of these 458 patients 424 patients had 
successfully completed the study. 
 
Material and Methods 
Study Design  Open labelled trial 
Sample Size   40 subjects per centre  
Level of Study   OPD  
Study Period  1 year  
 
Criteria for Inclusion 
1. Age between 15 to 60 years 
2. Haemoglobin level between 6 to 10 
gm /dl. 
3. Serum iron content < 50 μg /L                                                 
4. S. Ferritin < 30  μg /L                                                     
5. MCHC < 34 g/dl 
6. MCV < 80fL. 
7. Peripheral smear of blood shows hypo 
chromic / microcytic anaemia 
 
Criteria for Exclusion 
1. Age less than 15 years and more than 
60 years. 
2. Pregnancy and lactation 
3. Severe Renal / Hepatic/ Cardiac 
disease    
4. Any continuing blood loss e.g. 
Haematemesis, Melena, bleeding piles 
etc. 
5. Dimorphic anaemia  
 
Statistical Methods (1, 3) 
Let dij be the observed number of 
events (in this case presence of symptoms) 
and Yij the number of person time of 
observation in cluster j at assessment stage 
i, where i =1 represents the assessment 
stage I and i =2 represents the assessment 
stage II and so on.   And j = 1, 2, .......12 
since we have 12 clusters (5). The cluster 
event rates when computed by considering 
the mean of the cluster event rates at 
assessment stage i is given by  
 
12 12
1 1
1 1 ij
t ij
j ji i ij
d
r r
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    
And thus an estimate of the assessment 
stage effect is  
 
1 2/MRR r r  
 
Confidence Intervals (CI) 
A CI can be obtained for the 
intervention effect RRM by using the 
standard deviation of the cluster event 
rates in each group (2, 9).  
The distribution of RRM is likely to 
be skewed, and so we calculate a CI on 
logarithmic scale. Using a Taylor series 
approximation the variance of log (RRM) is 
estimated by 
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Is the estimated variance of the 
cluster rates in the i
th 
group. The sampling 
distribution of RRM will be asymptotically 
normal and a 95% CI for RRM is given by 
exp[log 1.96 ]M MRR V  
 
Results 
The Objective parameters under 
this study were Weakness, Fatigue, 
Palpitation, Effort intolerance, 
Breathlessness and Swollen feet. 
As seen by the results there was 
marked improvement in all chief 
complaints which were present at baseline 
in almost all the patients.  Remarkable 
improvement was found in weakness when 
compared to baseline as the percentage 
change was 8%, 20% and 38% 
respectively for 15
th
 day, 30
th
 day and 45
th
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day respectively, for fatigue improvement 
percentage was 10%, 26% and 49% for 
15
th
 day, 30
th
 day and 45
th
 day respectively 
on comparing from baseline, for 
Palpitation improvement percentage was 
22%, 49% and 69% for 15
th
 day, 30
th
 day 
and 45
th
 day respectively on comparing 
from baseline, for Effort intolerance 
improvement percentage was 18%, 50% 
and 75% for 15
th
 day, 30
th
 day and 45
th
 day 
respectively on comparing from baseline, 
for Breathlessness improvement 
percentage was 34%, 61% and 80% for 
15
th
 day, 30
th
 day and 45
th
 day respectively 
on comparing from baseline and for 
swollen feet improvement percentage was 
93%,96% and 98% improvement in 15
th
 
Day,30
th
 Day and 45
th
 day respectively. 
 
Table 1: Showing the cluster event rates of the chief complaints assessed after 15, 30 and 45 
days 
Chief Complaints Assessment Stages Mean N Std. Deviation 
Weakness 0 day 0.9938 12 0.0154 
15 day 0.9314 12 0.0922 
30 day 0.7781 12 0.1963 
45 day 0.5967 12 0.2530 
Fatigue 0 day 0.9803 12 0.0358 
15 day 0.8913 12 0.10384 
30 day 0.7088 12 0.2035 
45 day 0.4865 12 0.2700 
Palpitation 0 day 0.6004 12 0.2489 
15 day 0.4655 12 0.2401 
30 day 0.2994 12 0.2346 
45 day 0.1855 12 0.1791 
Effort intolerance 0 day 0.5831 12 0.3212 
15 day 0.4892 12 0.3204 
30 day 0.2986 12 0.2251 
45 day 0.1451 12 0.0986 
Breathlessness 0 day 0.5267 12 0.2701 
15 day 0.3450 12 0.2390 
30 day 0.2071 12 0.1713 
45 day 0.1126 12 0.1189 
Swollen feet 0 day 0.1293 12 0.0998 
15 day 0.0645 12 0.0450 
30 day 0.0328 12 0.0330 
45 day 0.0194 12 0.0222 
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Table 2: Showing the results of the Statistical Analysis of the cluster event rates of the chief 
complaints. It can be seen from the table below that the effect of the drug Dhatrilauha was 
significant on all the chief complaints as the p-value is less than 0.05 for all the parameters. 
 Paired Differences t-
value 
p-
value Mean Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Weakness 0 day - 15 day 0.0624 0.0844 0.0243 0.0087 0.1161 2.560 0.027 
0 day - 30 day 0.2157 0.1933 0.0558 0.0928 0.3385 3.865 0.003 
0 day - 45 day 0.3971 0.2476 0.0714 0.2398 0.5544 5.556 0.000 
Fatigue 0 day - 15 day 0.0889 0.1048 0.0302 0.0223 0.1555 2.939 0.013 
0 day - 30 day 0.2715 0.2048 0.0591 0.1414 0.4016 4.593 0.001 
0 day - 45 day 0.4937 0.2635 0.0760 0.3263 0.6612 6.490 0.000 
Palpitation 0 day - 15 day 0.1349 0.1197 0.0345 0.0588 0.2110 3.904 0.002 
0 day - 30 day 0.3010 0.1905 0.0549 0.1799 0.4220 5.474 0.000 
0 day - 45 day 0.4149 0.2340 0.0675 0.2662 0.5636 6.141 0.000 
Effort 
Intolerance 
0 day - 15 day 0.0938 0.0824 0.0238 0.0414 0.1462 3.942 0.002 
0 day - 30 day 0.2844 0.1630 0.0470 0.1808 0.3880 6.043 0.000 
0 day - 45 day 0.4379 0.2679 0.0773 0.2677 0.6082 5.662 0.000 
Breath-
lessness 
0 day - 15 day 0.1816 0.1829 0.0528 0.0654 0.2979 3.439 0.006 
0 day - 30 day 0.3196 0.2140 0.0617 0.1836 0.4556 5.174 0.000 
0 day - 45 day 0.4141 0.2648 0.0764 0.2458 0.5823 5.418 0.000 
Swollen 
feet 
0 day - 15 day 0.0647 0.0708 0.0204 0.0197 0.1097 3.166 0.009 
0 day - 30 day 0.0964 0.0900 0.0259 0.0392 0.1536 3.712 0.003 
0 day - 45 day 0.1098 0.0973 0.0281 0.0479 0.1716 3.909 0.002 
 
Hence we can say that cluster 
analysis of the binary outcome data is 
really fruitful and a good choice of the 
analysis technique when the sample size is 
large as the cluster analysis of the event 
rates give us a chance to treat each cluster 
as a separate unit.  
Hence we can say that the effect of 
the drug Dhatrilauha is really effective in 
treating the patients suffering from Iron 
Deficiency Anaemia. 
Conclusion  
Cluster trials are used in many area 
of health research and they have a 
particularly strong tradition behavioural 
and diseases prevention research. The 
primary feature of the cluster trial is the 
intra-cluster correlation that arises from 
assignment of treatment condition to intact 
groups of individuals. This means that 
special consideration is needed in the 
planning and conducting such trials which 
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is not required in clinical trials that 
randomize treatment to individuals. 
Because of such challenges, best plan to 
analyse the data is in the form of cluster 
trials. This is especially true for categorical 
outcomes and in those situations 
characterized by a small number of 
clusters, each with a large number of 
subjects per cluster. 
In the present study we have 
presented some simple practical 
approaches for the analysis of cluster 
randomized trials whose out come is an 
event rate (appearance of chief complaints 
per person time).The Confidence interval 
that we proposed are based on large 
sample theory as those are given by more 
complex method. 
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